CBU
ABMD

CIBC Bank USA’s Abiomed Inc ABMD Stock Holding History

CIBC Bank USA’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-910
Closed -$237K – 288
2019
Q2 		$237K Sell
910
-67
-7% -$17.8K 0.03% 236
2019
Q1 		$279K Sell
977
-58
-6% -$19.3K 0.04% 207
2018
Q4 		$336K Sell
1,035
-110
-10% -$38.2K 0.05% 179
2018
Q3 		$515K Sell
1,145
-115
-9% -$45.3K 0.07% 156
2018
Q2 		$515K Sell
1,260
-85
-6% -$30.8K 0.07% 152
2018
Q1 		$392K Sell
1,345
-205
-13% -$52K 0.05% 177
2017
Q4 		$290K Sell
1,550
-25
-2% -$4.67K 0.04% 200
2017
Q3 		$266K Hold
1,575
– – 0.03% 212
2017
Q2 		$226K Buy
+1,575
New +$212K 0.03% 242
2016
Q4 		– Sell
-1,575
Closed -$203K – 274
2016
Q3 		$203K Buy
+1,575
New +$189K 0.03% 237
2016
Q2 		– Sell
-2,350
Closed -$222K – 268
2016
Q1 		$222K Sell
2,350
-60
-2% -$5.07K 0.04% 206
2015
Q4 		$217K Hold
2,410
– – 0.04% 216
2015
Q3 		$224K Buy
+2,410
New +$212K 0.04% 216

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

CIBC Bank USA's ABMD Position: Q3 2019 in Review

CIBC Bank USA sold out of Abiomed Inc (ABMD) in Q3 2019, closing a stake of 910 shares — an estimated $237K sold.

CIBC Bank USA first reported a position in ABMD in Q3 2015 and held it in 13 quarters. The position peaked at $515K in Q3 2018. 443 funds tracked by Wall St. Rank hold ABMD as of Q3 2019.

  • CIBC Bank USA reported no remaining Abiomed Inc position as of Q3 2019 after selling out during the quarter.
  • CIBC Bank USA sold 910 Abiomed Inc shares in Q3 2019, an estimated $237K.
  • CIBC Bank USA first reported a position in Abiomed Inc in Q3 2015 and held it in 13 quarters.
  • CIBC Bank USA's Abiomed Inc position peaked at $515K in Q3 2018.
  • 443 funds tracked by Wall St. Rank held Abiomed Inc as of Q3 2019.

Based on CIBC Bank USA's 13F filing for Q3 2019, filed 22 Oct 2019.